0.5635
0.0086 (1.55%)
0.0086 (1.55%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 473,416 |
|
|||||
| News | (4) | ||||||
| Day High | 0.6307 | Low High |
|||||
| Day Low | 0.5362 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cidara Therapeutics Inc | CDTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.0086 | 1.55% | 0.5635 | 18:14:18 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.5999 | 0.5362 | 0.6307 | 0.52 | 0.5549 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 733 | 473,416 | $ 0.574768 | $ 272,104 | - | 0.40 - 2.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:36:20 | 50 | $ 0.5635 | USD |
Period:
Draw Mode:
Cidara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 38.91M | 69.05M | 67.97M | $ 49.57M | $ -40.14M | -0.86 | -0.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -654.00 | 3.50% |
Cidara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.50 | 0.6307 | 0.4306 | 0.5061763 | 322,071 | 0.0635 | 12.7% |
| 1 Month | 0.4442 | 0.6307 | 0.40 | 0.5025707 | 349,946 | 0.1193 | 26.86% |
| 3 Months | 0.86 | 0.95 | 0.40 | 0.582391 | 296,257 | -0.2965 | -34.48% |
| 6 Months | 1.39 | 1.41 | 0.40 | 0.7952687 | 327,258 | -0.8265 | -59.46% |
| 1 Year | 1.93 | 2.39 | 0.40 | 1.36 | 490,643 | -1.37 | -70.8% |
| 3 Years | 1.67 | 4.45 | 0.40 | 2.15 | 430,981 | -1.11 | -66.26% |
| 5 Years | 7.00 | 8.80 | 0.40 | 2.58 | 311,311 | -6.44 | -91.95% |
Cidara Therapeutics Description
| Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. |